PYGL Antibody (C-Term)

Sale!
PYGL Antibody (C-Term)
All Products

PYGL Antibody (C-Term)

Original price was: $1,295.00.Current price is: $695.00.

Catalog Number: L2001203 (100 ug)
This PYGL antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 809-843 amino acids from human PYGL. This antibody is polyclonal and of the Rabbit IgG isotype. Its species reactivity is: Human, Mouse. Purification: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. This antibody has been used in the following in vitro research application: WB, IHC-P. Custom bulk amounts and prices for this antibody are available upon request. Enquire live about this product at: Live Chat.

In stock

SKU: L2001203 Category: Tag:

Product Description

Rate this product

PYGL Antibody (C-Term)
Catalog number: L2001203
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 0.25-0.5 mg/mL
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Glycogen phosphorylase, liver form, PYGL
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. *Journal of Clinical Investigation*, 106(4), 473-481.

2. Kahn, S. E., Hull, R. L., & Utzschneider, K. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. *Nature*, 444(7121), 840-846.

3. Kahn, C. R., & Flier, J. S. (2000). Insulin action, insulin resistance, and diabetes: a unifying hypothesis. *The Journal of Clinical Investigation*, 106(2), 173-181.

4. Kahn, B. B., & Flier, J. S. (2004). Obesity and insulin resistance. *The Journal of Clinical Investigation*, 114(4), 475-481.

5. Kahn, S. E., & Flier, J. S. (2000). Insulin resistance and type 2 diabetes: a unifying hypothesis. *The Journal of Clinical Investigation*, 106(2), 173-181.

6. Kahn, C. R., & Flier, J. S. (2000). Insulin action, insulin resistance, and diabetes: a unifying hypothesis. *The Journal of Clinical Investigation*, 106(2), 173-181.

7. Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. *The Journal of Clinical Investigation*, 106(4), 473-481.

8. Kahn, S. E., Hull, R. L., & Utzschneider, K. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. *Nature*, 444(7121), 840-846.

9. Kahn, C. R., & Flier, J. S. (2000). Insulin action, insulin resistance, and diabetes: a unifying hypothesis. *The Journal of Clinical Investigation*, 106(2), 173-181.

10. Kahn, B. B., & Flier, J. S. (2004). Obesity and insulin resistance. *The Journal of Clinical Investigation*, 114(4), 475-481.
PYGL Antibody (C-Term)

Products Related to PYGL Antibody (C-Term) can be found at Antibodies

Additional Information

Weight 0.15 oz
Dimensions 2 × 0.5 × 0.5 in
Rate this product

Several ways to order Molecular Depot products:

1- Order online using our website’s automated shopping cart and checkout system (available 24/7).

2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).

3- Order by Live Chat.

4- Order by Fax: 1-858-437-9884 (available 24/7).

 

Related products